![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1672840
ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ(eTMF) ½ÃÀå : ¹èÆ÷ ¸ðµåº°, ±â´Éº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°Electronic Trial Master File (eTMF) Market, By Deployment Mode, By Functionality, By End User, By Geography |
¼¼°èÀÇ ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ(eTMF) ½ÃÀåÀº 2025³â¿¡´Â 20¾ï 9,000¸¸ ´Þ·¯, 2032³â¿¡´Â 48¾ï 1,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³âÀÇ CAGRÀº 12.6%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ ¼¼ºÎÁ¤º¸ | ||
---|---|---|---|
±âÁØ¿¬µµ | 2024³â | 2025³â ½ÃÀå ±Ô¸ð | 20¾ï 9,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2020-2024³â | ¿¹Ãø ±â°£ | 2025-2032³â |
¿¹Ãø ±â°£(2025-2032³â) CAGR: | 12.60% | 2032³â °¡Ä¡ ¿¹Ãø | 48¾ï 1,000¸¸ ´Þ·¯ |
ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ(eTMF) ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀº ¾÷°è Àü¹Ý¿¡ °ÉÃÄ ÀÓ»ó½ÃÇè ÇÁ·Î¼¼½º°¡ È®´ëµÇ°í ÀÖ´Ù´Â ¹è°æ¿¡ ÀÖ½À´Ï´Ù. eTMF´Â ¹®¼ °Ë»ö ¹× º¸°üÀ» ¿ëÀÌÇÏ°Ô Çϱâ À§ÇØ ¼³°èµÈ µðÁöÅÐ, ÀüÀÚ Çü½ÄÀ¸·Î ÀÓ»ó½ÃÇè°ú °ü·ÃµÈ ¹®¼ °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â ÅëÇÕ ½Ã½ºÅÛÀ» ¸»ÇÕ´Ï´Ù. Áß¿äÇÑ ÀÓ»ó½ÃÇè °ü·Ã ¹®¼¸¦ Á¶Á÷ÀûÀ¸·Î °ü¸®Çϰí ÀÓ»ó½ÃÇèÀÇ ¼ö¸íÁÖ±â Àü¹Ý¿¡ °ÉÃÄ °¡½Ã¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇè ÇÁ·Î¼¼½º°¡ º¹ÀâÇØÁö°í ±ÔÁ¦°¡ °ÈµÇ´Â °¡¿îµ¥ ÄÄÇöóÀÌ¾ð½º¿Í ¸ð´ÏÅ͸µÀÇ °È¸¦ È®º¸Çϱâ À§ÇØ ÀÓ»ó½ÃÇèÀ» ½Ç½ÃÇÏ´Â Á¶Á÷Àº eTMF ¼Ö·ç¼Ç¿¡ ´ëÇÑ Å« ¼ö¿ä°¡ ¿¹»óµË´Ï´Ù. ½ÃÀå ¼ºÀåÀº ±ÔÁ¦ Áؼö ¿ä°Ç, eTMF ºñ¿ë È¿À²¼º, ÀǾàǰ °³¹ß¿¡¼ R&D ÅõÀÚ Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù.
ÀÓ»ó½ÃÇè ¹®¼È ¹× µ¥ÀÌÅÍ °ü¸®¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÁöħÀº °¢ Áö¿ª¿¡¼ eTMF(ÀüÀÚ ½ÃÇè °ü·Ã ¹®¼) ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦ ±â°üÀº µ¥ÀÌÅÍ ¹«°á¼ºÀ» º¸ÀåÇϱâ À§ÇØ ÀüÀÚ ¾ÆÄ«À̺긦 ÅëÇÑ ÀûÀýÇÑ ¹®¼ °ü¸®¸¦ °Á¶ÇÕ´Ï´Ù. ½Å¾à °³¹ßÀ» À§ÇÑ Á¦¾à ±â¾÷ ¹× »ý¸í °øÇÐ ±â¾÷ÀÇ R&D ºñ¿ë Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ƯÈ÷ Áß¼Ò±â¾÷ÀÇ °æ¿ì eTMF ½Ã½ºÅÛÀÇ µµÀÔ ºñ¿ëÀÌ ³ô¾Æ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. eTMFÀÇ ºñ¿ë ÀÌÁ¡°ú ¹®¼ º¸¾È ¹× Á¢±Ù¼º Çâ»óÀº »õ·Î¿î ¼ºÀå ±âȸ¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. º¥´õ´Â ¶ÇÇÑ ¸ÂÃãÇü ±â¼ú°ú Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç¿¡ ÁýÁßÇϰí Á¢±Ù¼ºÀ» ´õ¿í Çâ»ó½ÃŰ°í ¿î¿µ ºñ¿ëÀ» ÁÙÀ̱â À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.
º» º¸°í¼¿¡¼´Â ¼¼°èÀÇ ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ(eTMF) ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025³â-2032³â) ½ÃÀå ±Ô¸ð ¹× CAGRÀ» Á¦°øÇÕ´Ï´Ù.
¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
¼¼°è eTMF(ÀüÀÚ ½ÃÇè °ü·Ã ¹®¼) ½ÃÀå¿¡¼ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î Á¦°øÇÕ´Ï´Ù.
º» ¿¬±¸ÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷Àº Veeva Systems Inc., Medidata Solutions, Inc., Oracle Corporation, Parexel International Corporation, IBM Watson Health, DrugDev(ÇöÀç VeevaÀÇ ÀϺÎ), MasterControl, Inc., Bioclinica, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂûÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°è eTMF(ÀüÀÚ ½ÃÇè °ü·Ã ¹®¼) ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚ´Â ¼¼°è eTMF(ÀüÀÚ ½ÃÇè °ü·Ã ¹®¼) ½ÃÀåÀ» ºÐ¼®Çϴµ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
Global Electronic Trial Master File (eTMF) Market is estimated to be valued at USD 2.09 Bn in 2025 and is expected to reach USD 4.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 2.09 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 12.60% | 2032 Value Projection: | USD 4.81 Bn |
Global electronic trial master file (eTMF) market growth is driven by growing clinical trial processes across industries. eTMF refers to an integrated system that facilitates management of documents related to clinical trials in a digital/electronic format designed for ease of retrieval and archiving of documents. It helps maintain crucial trial-related documents in an organized manner and improve visibility throughout the lifecycle of a clinical trial. With increasing complexities in clinical trial processes and stricter regulations, there will be huge demand for eTMF solutions among organizations conducting trials to ensure compliance and improved oversight. The market growth is driven by factors such as regulatory compliance requirements, cost-efficiency of eTMF, and increasing R&D investments in drug development.
Stringent regulatory guidelines around clinical trial documentation and data management across regions can drive the global electronic trial master file (eTMF) market growth. Regulatory bodies emphasize on maintaining proper documentation with electronic archiving to ensure data integrity. Rising R&D expenditure of pharmaceutical and biotechnology companies on new drug development can also drive the market growth. However, high implementation costs of eTMF systems especially for small and mid-sized companies can hamper the market growth. Cost benefits of eTMF along with better document security and accessibility can offer new growth opportunities. Vendors are also focusing on customizable technologies and cloud-based solutions to further enhance accessibility and lower operational costs.
This report provides in-depth analysis of the global electronic trial master file (eTMF) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global electronic trial master file (eTMF) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Veeva Systems Inc., Medidata Solutions, Inc., Oracle Corporation, Parexel International Corporation, IBM Watson Health, DrugDev (now part of Veeva), MasterControl, Inc., ArisGlobal LLC, Dassault Systemes, Trial Interactive, Signant Health, Forte Research Systems, Inc., Axiom Real-Time Metrics, eClinical Solutions, LLC, and Bioclinica, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global electronic trial master file (eTMF) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electronic trial master file (eTMF) market
Detailed Segmentation-